Filing Details

Accession Number:
0001209191-15-070216
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-10 19:03:06
Reporting Period:
2015-09-08
Filing Date:
2015-09-10
Accepted Time:
2015-09-10 19:03:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1621334 Pat Cotroneo C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Vp, Finance And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-08 2,500 $2.35 109,061 No 4 M Direct
Common Stock Disposition 2015-09-08 2,500 $26.00 106,561 No 4 S Direct
Common Stock Acquisiton 2015-09-08 690 $2.90 107,251 No 4 M Direct
Common Stock Acquisiton 2015-09-10 5,000 $2.35 112,251 No 4 M Direct
Common Stock Disposition 2015-09-10 5,000 $28.00 107,251 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-09-08 2,500 $0.00 2,500 $2.35
Common Stock Stock Option (Right to Buy) Disposition 2015-09-08 430 $0.00 430 $2.90
Common Stock Stock Option (Right to Buy) Disposition 2015-09-08 260 $0.00 260 $2.90
Common Stock Stock Option (Right to Buy) Disposition 2015-09-10 3,000 $0.00 3,000 $2.35
Common Stock Stock Option (Right to Buy) Disposition 2015-09-10 2,000 $0.00 2,000 $2.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,000 2018-03-12 No 4 M Direct
0 2020-06-24 No 4 M Direct
3,740 2020-06-24 No 4 M Direct
0 2018-03-12 No 4 M Direct
30,000 2018-03-12 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. Fully vested.